Islets from patients with T2D showed a 60% loss in glucose stimulated insulin secretion and a 2.2-fold increase in apoptosis, compared to islets isolated from non-diabetic controls (p < 0.05, Fig. 3D,F). The gene discussed is INS; the disease is type 2 diabetes mellitus.